Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism

New England Journal of Medicine

Volumn 350, Issue 22, 2004, Pages 2257-2264+2323

  Pengo, Vittorio ^a   Lensing, Anthonie W A ^b   Prins, Martin H ^c   Marchiori, Antonio ^a   Davidson, Bruce L ^d   Tiozzo, Francesca ^a   Albanese, Paolo ^a   Biasiolo, Alessandra ^a   Pegoraro, Cinzia ^a   Iliceto, Sabino ^a   Prandoni, Paolo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGE; AGED; ARTICLE; BLOOD FILTRATION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DYSPNEA; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONG TERM CARE; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG EMBOLISM; LUNG PERFUSION; LUNG SCINTISCANNING; LUNG SURGERY; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RISK FACTOR; SYMPTOM; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; VENA CAVA FILTER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; THROMBOEMBOLISM;

EID: 2442643903     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032274     Document Type: Article

References (20)

1. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
2. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395-9.
3. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-5.
4. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440-8.
5. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301-36.
6. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996;335:1816-28.
7. Lensing AWA, Prandoni P, Prins MH, Büller HR. Deep-vein thrombosis. Lancet 1999;353:479-85.
8. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998;339:93-104.
9. Otto CM. Textbook of clinical echocardiography. 2nd ed. Philadelphia: W.B. Saunders, 2000:123-31.
10. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182:393-8.
11. Meyer G, Collignon MA, Guinet F, Jeffrey AA, Barritault L, Sors H. Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism. Eur J Nucl Med 1990;17:315-9.
12. The Rembrandt Investigators. Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: a phase II evaluation. Circulation 2000;102:2726-31.
13. Miller GA, Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J 1971;2:681-4.
14. van Beek EJ, Kuijer PM, Buller HR, Brandjes DP, Bossuyt PM, ten Cate JW. The clinical course of patients with suspected pulmonary embolism. Arch Intern Med 1997;157:2593-8.
15. Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 1995;99:392-6.
16. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
17. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7. [Erratum, N Engl J Med 1997;337:1251.]
18. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7. [Erratum, N Engl J Med 1997;337:1251.]
19. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-62.
20. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-8.